Huntingtin Protein
Overview <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">Huntingtin Protein</th> </tr> <tr> <td class="label">Agent</td> <td>Target</td> </tr> <tr> <td class="label">Tominersen</td> <td>HTT ASO</td> </tr> <tr> <td class="label">ASO-HTTRx</td> <td>HTT</td> </tr> <tr> <td class="label">others</td> <td>Various</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">HAP40</td> <td>Protein binding</td> </tr> <tr> <td class="label">BDNF</td> <td>Transcriptional regulation</td> </tr> <tr> <td class="label">CBP/p300</td> <td>Transcription</td> </tr> <tr> <td class="label">RAB11</td> <td>Vesicle transport</td> </tr> <tr> <td class="label">p53</td> <td>[Apoptosis](/entities/apoptosis) regulation</td> </tr> </table>
[Huntingtin Protein](/proteins/huntingtin) is a protein that huntingtin is essential for embryonic development and has multiple functions in the adult nervous system[1]:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@huntingtin2020]
Structure Huntingtin (HTT) is one of the largest known proteins, with 3,144 amino acids in the canonical isoform. It is characterized by several structural features[1]:
Domain Architecture ...
Huntingtin Protein
Overview <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">Huntingtin Protein</th> </tr> <tr> <td class="label">Agent</td> <td>Target</td> </tr> <tr> <td class="label">Tominersen</td> <td>HTT ASO</td> </tr> <tr> <td class="label">ASO-HTTRx</td> <td>HTT</td> </tr> <tr> <td class="label">others</td> <td>Various</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">HAP40</td> <td>Protein binding</td> </tr> <tr> <td class="label">BDNF</td> <td>Transcriptional regulation</td> </tr> <tr> <td class="label">CBP/p300</td> <td>Transcription</td> </tr> <tr> <td class="label">RAB11</td> <td>Vesicle transport</td> </tr> <tr> <td class="label">p53</td> <td>[Apoptosis](/entities/apoptosis) regulation</td> </tr> </table>
[Huntingtin Protein](/proteins/huntingtin) is a protein that huntingtin is essential for embryonic development and has multiple functions in the adult nervous system[1]:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@huntingtin2020]
Structure Huntingtin (HTT) is one of the largest known proteins, with 3,144 amino acids in the canonical isoform. It is characterized by several structural features[1]:
Domain Architecture
N-terminal domain (1-90 aa) : Contains the polyglutamine (polyQ) tract (CAG repeat, normally 10-35)
HEAT repeat domain (90-1,700 aa) : ~23 HEAT repeats; mediates protein-protein interactions
Bridge region (1,700-2,200 aa) : Flexible linker with multiple proline-rich motifs
C-terminal domain (2,200-3,144 aa) : Contains additional HEAT repeats and regulatory sequences
The HEAT repeats form alpha-helical solenoids that mediate interactions with numerous partner proteins. The polyQ tract length determines pathogenicity—expansion beyond ~36 repeats causes Huntington's disease[1].
Post-Translational Modifications
Phosphorylation : At Ser-16, Ser-421, Thr-47 (neuroprotective)
Acetylation : At Lys-44, Lys-555 (affects aggregation and clearance)
Sumoylation : Multiple sites
Palmitoylation : At Cys-214 (membrane association)
Proteolytic cleavage : By caspases, calpains generating toxic N-terminal fragments
Normal Function Huntingtin is essential for embryonic development and has multiple functions in the adult nervous system[1]:
Vesicle Trafficking
Axonal transport : Associates with dynein/dynactin and kinesin for vesicle movement
Synaptic vesicle function : Regulates neurotransmitter release
Endocytic pathway : Involved in receptor trafficking
Gene Expression Regulation
Transcriptional co-activator : Interacts with p53, [NF-κB](/entities/nf-kb), and other transcription factors
Chromatin remodeling : Associates with histone acetyltransferases (CBP, p300)
BDNF transcription : Positively regulates BDNF expression
Cellular Protection
Anti-apoptotic function : Sequesters pro-apoptotic proteins
Mitochondrial function : Supports mitochondrial dynamics and quality
[Autophagy](/entities/autophagy) regulation : Involved in selective autophagy
Developmental Functions
Early development : Essential for gastrulation
Neuronal survival : Supports cortical and striatal neuron viability
Synapse formation : Regulates dendritic spine development
Role in Neurodegeneration
Huntington's Disease (HD) CAG repeat expansion (≥36 repeats) causes autosomal dominant Huntington's disease[1]:
Pathogenic Mechanisms
Toxic gain of function : Mutant HTT forms aggregates in [neurons](/entities/neurons)[2]
Loss of normal function : Disrupted protein interactions[2]
Transcriptional dysregulation : Altered gene expression patterns[2]
Mitochondrial dysfunction : Energy deficit and oxidative stress[2]
Axonal transport defects : Impaired vesicle trafficking
Neuropathology
Striatal degeneration : Medium spiny neurons particularly vulnerable
Cortical atrophy : Progressive loss of cortical volume
HTT inclusions : Mutant protein aggregates throughout brain
White matter changes : Demyelination and axonal loss
Systemic Features
Peripheral manifestations : Muscle wasting, metabolic changes
Cognitive decline : Executive dysfunction, eventually dementia
Psychiatric symptoms : Depression, anxiety, psychosis
Role in Other Neurodegenerative Diseases
Alzheimer's disease : HTT may interact with [APP](/entities/app-protein) and [tau](/proteins/tau)
Parkinson's disease : Altered autophagy in PD linked to HTT
ALS : HTT inclusions in some ALS cases
Mechanisms of Toxicity
Aggregate formation : Toxic oligomers and inclusions
Transcriptional dysregulation : Sequestration of transcriptional co-activators
Mitochondrial dysfunction : Impaired energy metabolism
Axonal transport disruption : Loss of neurotrophic support
Synaptic failure : Impaired neurotransmitter release
Therapeutic Targeting
Gene Silencing Approaches
Antisense oligonucleotides (ASOs) : Multiple clinical trials (e.g., Tominersen, others)
RNAi and CRISPR : Under development
Allele-specific targeting : Targeting mutant allele specifically
Protein-Targeting Strategies
Aggregation inhibitors : Small molecules to prevent aggregation
HTT phosphorylation : Modulating protective phosphorylation sites
Proteostasis enhancement : Autophagy inducers
Symptomatic Treatments
Motor symptoms : Tetrabenazine, VMAT2 inhibitor
Cognitive dysfunction : Under investigation
Psychiatric symptoms : Standard treatments
Disease Modification
Neuroprotective strategies : BDNF enhancement, mitochondrial protectants
Cell replacement therapy : Stem cell approaches under investigation
Gene therapy : AAV-delivered gene silencing
Clinical Trials
Protein Interactions
See Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Unknown, Huntingtin structure and function (Cell 2020) (2020)](https://doi.org/10.1016/j.cell.2020.06.025)
[Unknown, Huntington's disease pathogenesis (Nat Rev Neurosci 2021) (2021)](https://doi.org/10.1038/s41583-021-00478-0)
Show full description